Atlas-backed Kymera signs deal with Vertex worth up to $1B
May 15, 2019 at 11:04 AM EDT
Cambridge startup Kymera Therapeutics just earned $70 million and could get up to $1 billion after signing a four-year collaboration deal with Vertex Pharmaceuticals.
